Journey Medical Corporation/$DERM
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Journey Medical Corporation
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
- Ticker
- $DERM
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 58
- Headquarters
- Scottsdale, United States
- Website
- journeymedicalcorp.com
DERM Metrics
BasicAdvanced
$125M
-
-$0.23
1.10
-
Price and volume
Market cap
$125M
Beta
1.1
52-week high
$9.56
52-week low
$4.25
Average daily volume
184K
Financial strength
Current ratio
1.59
Quick ratio
1.352
Long term debt to equity
0.637
Total debt to equity
0.795
Interest coverage (TTM)
-0.82%
Profitability
EBITDA (TTM)
1.216
Gross margin (TTM)
65.45%
Net profit margin (TTM)
-8.95%
Operating margin (TTM)
-4.41%
Effective tax rate (TTM)
-0.25%
Revenue per employee (TTM)
$1,180,000
Management effectiveness
Return on assets (TTM)
-2.09%
Return on equity (TTM)
-23.77%
Valuation
Price to revenue (TTM)
1.74
Price to book
3.82
Price to tangible book (TTM)
18.59
Price to free cash flow (TTM)
-15.836
Free cash flow yield (TTM)
-6.31%
Free cash flow per share (TTM)
-0.28
Growth
Revenue change (TTM)
20.89%
Earnings per share change (TTM)
-41.95%
3-year revenue growth (CAGR)
3.52%
3-year earnings per share growth (CAGR)
-53.03%
What the Analysts think about DERM
Analyst ratings (Buy, Hold, Sell) for Journey Medical Corporation stock.
Analyst projections of the future price of Journey Medical Corporation stock.
DERM Financial Performance
Revenues and expenses
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.